553 related articles for article (PubMed ID: 18651175)
1. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence.
Smith RJ; Aston-Jones G
Brain Struct Funct; 2008 Sep; 213(1-2):43-61. PubMed ID: 18651175
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization.
Huang MM; Overstreet DH; Knapp DJ; Angel R; Wills TA; Navarro M; Rivier J; Vale W; Breese GR
J Pharmacol Exp Ther; 2010 Jan; 332(1):298-307. PubMed ID: 19843974
[TBL] [Abstract][Full Text] [Related]
3. Brain substrates for increased drug seeking during protracted withdrawal.
Aston-Jones G; Harris GC
Neuropharmacology; 2004; 47 Suppl 1():167-79. PubMed ID: 15464135
[TBL] [Abstract][Full Text] [Related]
4. Neurocircuitry of alcohol addiction: synthesis from animal models.
Koob GF
Handb Clin Neurol; 2014; 125():33-54. PubMed ID: 25307567
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats.
Funk CK; O'Dell LE; Crawford EF; Koob GF
J Neurosci; 2006 Nov; 26(44):11324-32. PubMed ID: 17079660
[TBL] [Abstract][Full Text] [Related]
6. Differential behavioral and molecular alterations upon protracted abstinence from cocaine versus morphine, nicotine, THC and alcohol.
Becker JAJ; Kieffer BL; Le Merrer J
Addict Biol; 2017 Sep; 22(5):1205-1217. PubMed ID: 27126842
[TBL] [Abstract][Full Text] [Related]
7. Chronic Intermittent Ethanol and Acute Stress Similarly Modulate BNST CRF Neuron Activity via Noradrenergic Signaling.
Snyder AE; Salimando GJ; Winder DG; Silberman Y
Alcohol Clin Exp Res; 2019 Aug; 43(8):1695-1701. PubMed ID: 31141179
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats.
Marcinkiewcz CA; Prado MM; Isaac SK; Marshall A; Rylkova D; Bruijnzeel AW
Neuropsychopharmacology; 2009 Jun; 34(7):1743-52. PubMed ID: 19145226
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin releasing factor and norepinephrine related circuitry changes in the bed nucleus of the stria terminalis in stress and alcohol and substance use disorders.
Snyder AE; Silberman Y
Neuropharmacology; 2021 Dec; 201():108814. PubMed ID: 34624301
[TBL] [Abstract][Full Text] [Related]
10. Regulation of CRF mRNA in the Rat Extended Amygdala Following Chronic Cocaine: Sex Differences and Effect of Delta Opioid Receptor Agonism.
Connelly KL; Unterwald EM
Int J Neuropsychopharmacol; 2020 Feb; 23(2):117-124. PubMed ID: 31867624
[TBL] [Abstract][Full Text] [Related]
11. Addiction as a stress surfeit disorder.
Koob GF; Buck CL; Cohen A; Edwards S; Park PE; Schlosburg JE; Schmeichel B; Vendruscolo LF; Wade CL; Whitfield TW; George O
Neuropharmacology; 2014 Jan; 76 Pt B(0 0):370-82. PubMed ID: 23747571
[TBL] [Abstract][Full Text] [Related]
12. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors.
Weiss F; Ciccocioppo R; Parsons LH; Katner S; Liu X; Zorrilla EP; Valdez GR; Ben-Shahar O; Angeletti S; Richter RR
Ann N Y Acad Sci; 2001 Jun; 937():1-26. PubMed ID: 11458532
[TBL] [Abstract][Full Text] [Related]
13. Stress-induced relapse to drug seeking in the rat: role of the bed nucleus of the stria terminalis and amygdala.
Erb S; Shaham Y; Stewart J
Stress; 2001 Dec; 4(4):289-303. PubMed ID: 22432148
[TBL] [Abstract][Full Text] [Related]
14. Interactions of norepinephrine and galanin in the central amygdala and lateral bed nucleus of the stria terminalis modulate the behavioral response to acute stress.
Morilak DA; Cecchi M; Khoshbouei H
Life Sci; 2003 Jun; 73(6):715-26. PubMed ID: 12801593
[TBL] [Abstract][Full Text] [Related]
15. Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA.
Pollandt S; Liu J; Orozco-Cabal L; Grigoriadis DE; Vale WW; Gallagher JP; Shinnick-Gallagher P
Eur J Neurosci; 2006 Sep; 24(6):1733-43. PubMed ID: 17004937
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the relationship between anxiety during withdrawal and stress-induced reinstatement of cocaine seeking.
Erb S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Jun; 34(5):798-807. PubMed ID: 19969038
[TBL] [Abstract][Full Text] [Related]
17. Brain stress systems in the amygdala and addiction.
Koob GF
Brain Res; 2009 Oct; 1293():61-75. PubMed ID: 19332030
[TBL] [Abstract][Full Text] [Related]
18. Localization of the delta opioid receptor and corticotropin-releasing factor in the amygdalar complex: role in anxiety.
Reyes BAS; Kravets JL; Connelly KL; Unterwald EM; Van Bockstaele EJ
Brain Struct Funct; 2017 Mar; 222(2):1007-1026. PubMed ID: 27376372
[TBL] [Abstract][Full Text] [Related]
19. Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal.
McNally GP; Akil H
Neuroscience; 2002; 112(3):605-17. PubMed ID: 12074902
[TBL] [Abstract][Full Text] [Related]
20. The role of CRF and CRF-related peptides in the dark side of addiction.
Koob GF
Brain Res; 2010 Feb; 1314():3-14. PubMed ID: 19912996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
